Central Nervous System Neoplasm — Trials

Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,058 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 627 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03220035	Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)	completed	Phase 2	4	National Cancer Institute (NCI)NIH	2	Jan 27, 2025	clinicaltrials
NCT02960230	H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas	completed	Phase 1 / Phase 2	50	Sabine Mueller, MD, PhDOTHER	2	Jan 22, 2025